List of Studies

Back
Study IDStudy TitleLanguage Clinical Study Result Plain Language Summary
9463-CL-2101A Phase 1, Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin (FK463) in Children (2 - 5 Years and 6 - 11 Years) and Adolescents (12 - 16 Years) with Esophageal Candidiasis or Other Invasive Candidiasis English


English


9463-CL-2303A Phase 3, Randomized, Double-Blind, Multi-Center Study to Compare the Efficacy and Safety of Micafungin Versus Amphotericin B Deoxycholate for the Treatment of Neonatal Candidiasis English


English


9463-CL-6001Determination of Plasmatic and CSF Levels of High Doses of Micafungin in Neonates Suffering from Systemic Candidiasis and/or Candida Meningitis English


English


9463-EC-0001Randomized, Open label, Non-inferiority Study of Micafungin Versus Standard Care for the Prevention of Invasive Fungal Disease in High Risk Liver Transplant Recipients English


English


NextLast

QUICK SEARCH

USEFUL LINKS